טוען...
CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver
Human cytochrome P450 (CYP) 2C enzymes metabolize ∼30% of clinically prescribed drugs and various environmental chemicals. CYP2C8, an important member of this subfamily, metabolizes the anticancer drug paclitaxel, certain antidiabetic drugs, and endogenous substrates, including arachidonic acid, to...
שמור ב:
| הוצא לאור ב: | Mol Pharmacol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The American Society for Pharmacology and Experimental Therapeutics
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4702104/ https://ncbi.nlm.nih.gov/pubmed/26467040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.100255 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|